Published in Am J Surg on January 01, 1996
Obesity adversely affects the outcome of antireflux operations. Surg Endosc (2001) 2.11
Mesh repairs in hiatal surgery. The case against mesh repairs in hiatal surgery. Ann R Coll Surg Engl (2007) 2.06
Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision. Ann Surg (1999) 1.85
Psychiatric disorders affect outcomes of antireflux operations for gastroesophageal reflux disease. Surg Endosc (2001) 1.45
Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg (1999) 1.40
Surgical reintervention after failed antireflux surgery: a systematic review of the literature. J Gastrointest Surg (2009) 1.15
Metabolic changes in the lower esophageal sphincter influencing the result of anti-reflux surgical interventions in chronic gastroesophageal reflux disease. World J Gastroenterol (2005) 0.95
Tension-free repair of hiatal hernia during laparoscopic fundoplication: a ten-year experience. Hernia (2005) 0.88
Identification of risk factors for postoperative dysphagia after primary anti-reflux surgery. Surg Endosc (2010) 0.86
Laparoscopic fundoplication is the treatment of choice for gastro-oesophageal reflux disease. Protagonist. Gut (2002) 0.86
Reoperation rates after laparoscopic fundoplication. Surg Endosc (2014) 0.84
Austrian experiences with redo antireflux surgery. Surg Endosc (2005) 0.83
Anatomical failure following laparoscopic antireflux surgery (LARS): does it really matter? Ann R Coll Surg Engl (2009) 0.83
Impaired postoperative EGJ relaxation as a determinant of post laparoscopic fundoplication dysphagia: a study with high-resolution manometry before and after surgery. Surg Endosc (2012) 0.83
Outcomes after esophagectomy in patients with prior antireflux or hiatal hernia surgery. Ann Thorac Surg (2010) 0.81
Radiofrequency energy delivery to the lower esophageal sphincter (Stretta procedure) in patients with recurrent reflux after antireflux surgery: can surgery be avoided? Surg Endosc (2007) 0.81
Quality of life before and after laparoscopic Nissen fundoplication. Surg Endosc (2001) 0.79
Vagus nerve injury with severe diarrhea after laparoscopic antireflux surgery. Dig Dis Sci (2002) 0.79
MRI patterns of Nissen fundoplication: normal appearance and mechanisms of failure. Eur Radiol (2014) 0.78
The Nissen fundoplication: indication, technical aspects and postoperative outcome. Langenbecks Arch Surg (2004) 0.78
Endoscopic clipping of the Z-line (CMZL) helps recognize anatomical failures after Nissen fundoplication: technical report of a new method. Wideochir Inne Tech Maloinwazyjne (2015) 0.75
Radiologic and endoscopic characteristics of laparoscopic antireflux wrap: correlation with outcome. Int Surg (2012) 0.75
Unilateral versus bilateral wrap crural fixation in laparoscopic Nissen fundoplication for children. JSLS (2014) 0.75
Robotic redo fundoplication for incompetent wrapping after antireflux surgery: A case report. Int J Surg Case Rep (2011) 0.75
A comparison between fluoroscopically guided radiofrequency energy delivery and conventional technique in an animal model of fundoplication failure. Surg Endosc (2007) 0.75
Relapsing cardial stenosis after laparoscopic nissen treated by esophageal stenting. Dysphagia (2003) 0.75
Evaluation of gastrectomy in patients with delayed gastric emptying after antireflux surgery or large hiatal hernia repair. World J Surg (2013) 0.75
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res (1994) 4.51
Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Dis Esophagus (1997) 3.06
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg (1992) 2.54
EndoResect study: endoscopic full-thickness resection of gastric subepithelial tumors. Endoscopy (2012) 2.44
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer (1993) 2.01
Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg (1998) 1.99
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol (1989) 1.81
Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg (1998) 1.78
Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg (1995) 1.77
Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy (1999) 1.76
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry (2002) 1.70
Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication. J Gastrointest Surg (1999) 1.69
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology (1992) 1.68
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol (1999) 1.61
Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg (2000) 1.61
Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg (1999) 1.60
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57
Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg (1999) 1.56
Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer. Lancet (1994) 1.56
Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg (2001) 1.55
[Bile duct lesions in laparoscopic cholecystectomy]. Chirurg (1994) 1.53
Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc (1991) 1.52
[Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma]. Dtsch Med Wochenschr (1996) 1.50
Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma. Br J Surg (2006) 1.49
Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer (1998) 1.49
Enucleation of submucosal tumors of the esophagus: minimally invasive versus open approach. Surg Endosc (2004) 1.46
Aerobilia and hypomotility of the sphincter of Oddi in a patient with chronic intestinal pseudo-obstruction. Gastroenterology (1992) 1.46
Cancer of the esophagogastric junction. Surg Oncol (2000) 1.45
Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun (1997) 1.44
New technique for temporary purse string suture in stapler anastomosis. Br J Surg (1990) 1.43
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial. Br J Cancer (2008) 1.42
A new concept in the surgical treatment of gastroesophageal reflux. Ann Surg (1983) 1.41
Randomized controlled trial of ultrasonic dissection versus standard surgical technique in open left hemicolectomy or total gastrectomy. Br J Surg (2011) 1.41
Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg (2000) 1.41
An innovative, safe and sterile sigmoid access (ISSA) for NOTES. Endoscopy (2007) 1.39
Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet (2004) 1.38
[Position paper on transplant surgery in visceral surgery]. Chirurg (1999) 1.38
NOTES for the cardia: antireflux therapy via transluminal access. Endoscopy (2010) 1.38
Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery (1997) 1.37
Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res (1994) 1.36
Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg (1994) 1.35
[Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg (1987) 1.35
Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer (1993) 1.33
New developments in the treatment of gastric carcinoma. Semin Oncol (1990) 1.32
Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer. Br J Cancer (2006) 1.30
Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery. Am J Surg (1999) 1.29
Prognostic factors of resected adenocarcinoma of the esophagus. Surgery (1995) 1.24
Three-dimensional pressure image and muscular structure of the human lower esophageal sphincter. Surgery (1995) 1.24
Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial. Hepatology (1985) 1.23
Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg (1997) 1.23
Analysis for microsatellite instability and mutations of the DNA mismatch repair gene hMLH1 in familial gastric cancer. Int J Cancer (1996) 1.22
Radical transhiatal esophagectomy with two-field lymphadenectomy and endodissection for distal esophageal adenocarcinoma. World J Surg (1997) 1.20
When is esophagitis healed? esophageal endoscopy, histology and function before and after cimetidine treatment. Dig Dis Sci (1982) 1.20
Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19
Development, standardization, and evaluation of NOTES cholecystectomy using a transsigmoid approach in the porcine model: an acute feasibility study. Endoscopy (2007) 1.19
Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol (2006) 1.18
Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia (1993) 1.18
Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history. Am J Pathol (1995) 1.15
Factors influencing survival after resection of pulmonary metastases from colorectal cancer. Br J Surg (2004) 1.15
Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses - analysis of 93 interventions. World J Surg (2008) 1.15
Palliative treatment of malignant stenoses of the upper gastrointestinal tract using a combination of laser and afterloading therapy. Endoscopy (1986) 1.15
Prognostic factors in gastric stump carcinoma. Ann Surg (2000) 1.14
Role of endoscopic ultrasonography in gastric carcinoma. Endoscopy (1993) 1.13
Comparative evaluation of HD 2D/3D laparoscopic monitors and benchmarking to a theoretically ideal 3D pseudodisplay: even well-experienced laparoscopists perform better with 3D. Surg Endosc (2014) 1.13
Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol (2005) 1.11
Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus. Surg Endosc (2002) 1.09
Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol (1996) 1.09
Vascular anatomy of the gastric tube used for esophageal reconstruction. Ann Thorac Surg (1992) 1.08
Prospective evaluation of the use of endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy. Endoscopy (1992) 1.08
Pneumatosis cystoides intestinalis coli. Surg Endosc (2002) 1.08
Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol (1998) 1.07
Fibrovascular esophageal polyp as a diagnostic challenge. Dis Esophagus (2000) 1.07
Transgastric in vivo histology in the peritoneal cavity using miniprobe-based confocal fluorescence microscopy in an acute porcine model. Endoscopy (2007) 1.06
Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial. World J Surg (1997) 1.06
Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol (2004) 1.06
Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg (1996) 1.05
Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc (2000) 1.05
Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J Thorac Cardiovasc Surg (1996) 1.05
The "ELITE" model: construct validation of a new training system for natural orifice transluminal endoscopic surgery (NOTES). Endoscopy (2009) 1.04
Role of endoscopic ultrasonography in esophageal carcinoma. Endoscopy (1993) 1.04
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up. Cancer (2001) 1.03
Bile acids as components of the duodenogastric refluxate: detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepatogastroenterology (1999) 1.03
Impact of iterative reconstruction on CNR and SNR in dynamic myocardial perfusion imaging in an animal model. Eur Radiol (2012) 1.01
The 'angiogenic switch' in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Eur J Surg Oncol (2003) 1.01